InspireMD (NSPR) Assets Growth (3y) (2013 - 2025)
InspireMD (NSPR) Assets Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | InspireMD | 56.92 Mn | 2.71 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 41.20% |
| Sep 30, 2025 | 40.89% |
| Jun 30, 2025 | 0.58% |
| Mar 31, 2025 | 3.21% |
| Dec 31, 2024 | 5.63% |
| Sep 30, 2024 | 5.82% |
| Jun 30, 2024 | 6.27% |
| Mar 31, 2024 | -4.75% |
| Dec 31, 2023 | 38.90% |
| Sep 30, 2023 | 47.43% |
| Jun 30, 2023 | 44.60% |
| Mar 31, 2023 | 39.20% |
| Dec 31, 2022 | 35.63% |
| Sep 30, 2022 | 34.16% |
| Jun 30, 2022 | 52.25% |
| Mar 31, 2022 | 51.79% |
| Dec 31, 2021 | 47.85% |
| Sep 30, 2021 | 45.15% |
| Jun 30, 2021 | 69.81% |
| Mar 31, 2021 | 88.30% |